KINEMED, INC. INVESTORS’ RIGHTS AGREEMENT January 9, 2009Investors’ Rights Agreement • April 3rd, 2014 • Kinemed Inc • Services-commercial physical & biological research • California
This Investors’ Rights Agreement (this “Agreement”) is dated as of January 9, 2009, and is between KineMed, Inc., a Delaware corporation (the “Company”), and the persons and entities listed on Exhibit A (each, an “Investor” and collectively, the “Investors”).
WARRANT TO PURCHASE SHARESKinemed Inc • April 3rd, 2014 • Services-commercial physical & biological research • Delaware
THIS WARRANT is issued to [ ] (the “Stockholder”) by KineMed, Inc., a Delaware corporation (the “Company.”). This Warrant is granted as of December 30, 2013 (the “Warrant Issue Date”) pursuant to the terms of that certain Placement Agent Agreement, dated as of December [ ], 2013, between the Company and [ ] (the “Placement Agent Agreement”).
COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • April 3rd, 2014 • Kinemed Inc • Services-commercial physical & biological research • Delaware
This COLLABORATION AND LICENSE AGREEMENT (the “Agreement”) is effective as of the 12th day of June, 2012 (the “Effective Date”) by and between KineMed, Inc., a Delaware company located at 5980 Horton Street, Suite 470, Emeryville, CA 94608 (“KineMed”) and Glaxo Group Limited, a company organized under the laws of England and Wales, having its registered office at Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex, UB6 ONN, England (“GSK”). Each of KineMed and GSK may be referred to herein as a “Party” or collectively as the “Parties”.
